Inhibikase Therapeutics shares owned by Royal Bank of Canada
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Royal Bank of Canada
from 13F filings
Historical chart of Royal Bank of Canada investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Inhibikase Therapeutics by Royal Bank of Canada
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $3.0k | 2.0k | 1.50 |